Recovery From Alopecia After COVID-19

The document presents a case of a 64-year-old man who experienced significant hair loss, diagnosed as telogen effluvium (TE), one month after being discharged from the hospital for severe COVID-19. This condition, which is a common sequela of COVID-19 affecting approximately 20% of patients, is typically reversible and improves without treatment. In this case, the patient's hair volume returned to nearly pre-infection levels seven months after his initial COVID-19 diagnosis. The patient was prescribed oral cepharanthine and topical carpronium due to his anxiety, although these treatments were not deemed necessary. The document emphasizes the importance of physicians explaining the condition to patients, sharing medical information, and managing systemic complications to alleviate psychophysical stress.